Tianeptine (Johnson & Johnson)

噻奈普汀

Report date: 2025/12/02 15:16:23

Base Information

Drug NameTianeptine (Johnson & Johnson)
Drug Alias NameTPI-1062JNJ-39823277
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake stimulants
TargetsSerotonin transporter
Therapy Area/IndicationsDepressive Disorder
Global Approved IndicationsDepressive Disorder
Approved Indications in ChinaDepressive Disorder
Original Approved Country/TerritoryMainland China
Original Approved Date1999/06/22
Country/TerritoryBelgiumUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesLes Laboratoires Servier
Inactive CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
Active IndicationsDepressive Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A